Total Payments
$1,717
2024 Payments
$141.72
Companies
29
Transactions
95
Medicare Patients
2,125
Medicare Billing
$306,540
Payment Breakdown by Category
Food & Beverage$1,515 (88.2%)
Education$202.26 (11.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,515 | 91 | 88.2% |
| Education | $202.26 | 4 | 11.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $274.45 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $193.05 | 9 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $160.13 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $108.47 | 1 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $103.72 | 6 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $98.39 | 7 | $0 (2020) |
| Boston Scientific Corporation | $89.71 | 4 | $0 (2024) |
| PFIZER INC. | $69.33 | 5 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $65.85 | 5 | $0 (2024) |
| Akrimax Pharmaceuticals, LLC | $54.42 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.72 | 7 | Boston Scientific Corporation ($44.12) |
| 2023 | $177.67 | 11 | Sumitomo Pharma America, Inc. ($144.03) |
| 2022 | $255.16 | 10 | Janssen Biotech, Inc. ($99.05) |
| 2021 | $42.55 | 3 | Myovant Sciences Inc. ($15.52) |
| 2020 | $57.66 | 4 | Dendreon Pharmaceuticals LLC ($16.42) |
| 2019 | $487.30 | 24 | Astellas Pharma US Inc ($160.38) |
| 2018 | $288.78 | 21 | PFIZER INC. ($44.39) |
| 2017 | $266.03 | 15 | Ferring Pharmaceuticals Inc. ($63.57) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 06/25/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $33.42 | General |
| Category: UROLOGY | ||||||
| 02/23/2024 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 02/01/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: UROLOGY | ||||||
| 01/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: UROLOGY | ||||||
| 01/23/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: AMS 700_URO | ||||||
| 12/19/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Urology | ||||||
| 12/15/2023 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 10/03/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Urology | ||||||
| 06/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Urology | ||||||
| 05/09/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Urology | ||||||
| 04/25/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: HORMONE THERAPY | ||||||
| 04/04/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Urology | ||||||
| 02/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Urology | ||||||
| 01/18/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Urology | ||||||
| 01/17/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Urology | ||||||
| 01/10/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: HORMONE THERAPY | ||||||
| 12/27/2022 | Boston Scientific Corporation | General - Erectile Dysfunction (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/27/2022 | Boston Scientific Corporation | General - Erectile Dysfunction (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 11/15/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Oncology | ||||||
| 10/18/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Urology | ||||||
| 08/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Oncology | ||||||
| 07/20/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Urology | ||||||
| 06/02/2022 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: CONTINENCE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 430 | 597 | $232,300 | $53,985 |
| 2022 | 13 | 654 | 930 | $379,585 | $92,684 |
| 2021 | 11 | 662 | 1,151 | $425,865 | $105,714 |
| 2020 | 7 | 379 | 568 | $210,595 | $54,157 |
Total Patients
2,125
Total Services
3,246
Medicare Billing
$306,540
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 283 | $87,370 | $20,544 | 23.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 68 | $43,080 | $10,032 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $36,660 | $8,571 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 46 | $19,975 | $4,658 | 23.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 13 | 20 | $17,595 | $4,391 | 25.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 41 | $9,860 | $2,827 | 28.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $11,055 | $1,390 | 12.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 17 | $3,315 | $777.31 | 23.4% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 28 | 31 | $1,960 | $430.92 | 22.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 13 | 13 | $1,430 | $363.74 | 25.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 101 | 133 | $86,190 | $22,167 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 296 | $91,630 | $21,150 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $59,235 | $13,584 | 22.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 175 | $41,020 | $10,806 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 61 | $26,525 | $6,642 | 25.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 22 | 26 | $22,960 | $5,572 | 24.3% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2022 | 13 | 13 | $18,355 | $4,802 | 26.2% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2022 | 13 | 13 | $9,405 | $2,518 | 26.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 18 | 18 | $7,820 | $1,757 | 22.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 23 | 23 | $7,130 | $1,717 | 24.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 21 | $4,090 | $1,090 | 26.7% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 29 | 32 | $2,080 | $461.00 | 22.2% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2022 | 14 | 14 | $3,145 | $417.36 | 13.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 131 | 161 | $107,065 | $27,564 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 110 | 438 | $105,120 | $27,216 | 25.9% |
About David Chang
David Chang is a Urology healthcare provider based in North Bergen, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487622718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Chang has received a total of $1,717 in payments from pharmaceutical and medical device companies, with $141.72 received in 2024. These payments were reported across 95 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,515).
As a Medicare-enrolled provider, Chang has provided services to 2,125 Medicare beneficiaries, totaling 3,246 services with total Medicare billing of $306,540. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location North Bergen, NJ
- Active Since 03/11/2006
- Last Updated 12/18/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1487622718
Products in Payments
- GEMTESA (Drug) $127.19
- ELIQUIS (Drug) $108.47
- ERLEADA (Drug) $99.05
- PROVENGE (Drug) $98.39
- FIRMAGON (Drug) $91.05
- XTANDI (Drug) $90.71
- Erleada (Drug) $79.43
- MYRBETRIQ (Drug) $72.38
- Stendra (Drug) $68.75
- XIAFLEX (Biological) $65.85
- Myrbetriq (Drug) $50.40
- ORGOVYX (Drug) $48.46
- General - Erectile Dysfunction (Device) $45.59
- Noctiva (Drug) $42.60
- INTERSTIM (Device) $37.97
- Xtandi (Drug) $34.88
- AQUABEAM SYSTEM (Device) $33.42
- CALDOLOR (Drug) $32.57
- RYDAPT (Drug) $30.85
- Androgel (Drug) $26.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.